Skip to main
NTHI

NTHI Stock Forecast & Price Target

NTHI Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

NeOnc Technologies Hldgs is a biotech company with a strong pipeline and promising lead drugs targeting CNS tumors. With potential market entries in 2030 and 2031 and key catalysts expected in 2026 and 2027, the company has a solid outlook for growth. Additionally, their multiple patents and valuation based on a DCF analysis further support a positive outlook for investors.

Bears say

NeOnc Technologies Hldgs is a clinical-stage biopharmaceutical company focused on developing novel drug delivery technologies and treatments for central nervous system diseases, with a focus on intracranial malignancies. However, the company faces significant competitive, commercial, and political risks, and their lead product candidates are not expected to have phase II clinical data until 2026. Additionally, the company's potential pivotal trial and its mechanism of action rely on still unproven assumptions about drug activity, and the company's leadership has a relatively short track record in the industry.

NTHI has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neonc Technologies Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neonc Technologies Holdings Inc (NTHI) Forecast

Analysts have given NTHI a Strong Buy based on their latest research and market trends.

According to 3 analysts, NTHI has a Strong Buy consensus rating as of Jun 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neonc Technologies Holdings Inc (NTHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.